Ascendis Pharma A/S (ASND)
220.77
-1.26
(-0.57%)
USD |
NASDAQ |
Feb 10, 14:01
Ascendis Pharma Market Cap : 13.49B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 219.09B |
| Evaxion AS | 21.16M |
| DBV Technologies SA | 639.58M |
| Cellectis SA | 388.26M |
| Biodexa Pharmaceuticals Plc | 1.090M |
Market Cap Related Metrics
| PS Ratio | 18.46 |
| Price | 220.77 |
| Earnings Yield | -1.92% |